Skip to main content
. 2012 Mar 16;3(6):1293–1296. doi: 10.3892/ol.2012.646

Figure 2.

Figure 2

MRI-scan (T2-weighted images) of the brain during sunitinib therapy at (A) presentation with RPLS, (B) during everolimus therapy (six weeks after sunitinib was stopped) and (C) 2 weeks after cessation of everolimus. Extensive edema is evident in the right parieto-temporal, right parietal and left parieto-occipital areas of the brain. RPLS, reversible posterior leukoencephalopathy syndrome.